Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,018 | -13,699 | -10,287 | -6,643 | -3,504 |
| Depreciation Amortization | 224 | 885 | 655 | 427 | 207 |
| Accounts receivable | -151 | -7,427 | -4,891 | -2,927 | -596 |
| Accounts payable and accrued liabilities | 98 | -85 | -295 | -36 | -310 |
| Other Working Capital | -95 | -8,191 | -5,875 | -3,123 | -1,276 |
| Other Operating Activity | 2,063 | 14,216 | 10,111 | 6,022 | 2,385 |
| Operating Cash Flow | $-1,880 | $-14,300 | $-10,581 | $-6,279 | $-3,095 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -48 | -32 | -91 | -30 |
| Purchase Sale Intangibles | 0 | -54 | -54 | -44 | -15 |
| Other Investing Activity | 0 | -54 | -54 | -44 | -15 |
| Investing Cash Flow | $-2 | $-102 | $-86 | $-135 | $-45 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -34 | 500 | 500 | 500 | N/A |
| Debt Issued | 1,481 | 8,114 | 8,114 | N/A | N/A |
| Common Stock Issued | N/A | 23 | 23 | 23 | 18 |
| Other Financing Activity | -23 | -169 | -138 | -98 | -48 |
| Financing Cash Flow | $1,423 | $8,469 | $8,499 | $426 | $-30 |
| Exchange Rate Effect | -28 | 8 | -22 | -23 | -22 |
| Beginning Cash Position | 2,223 | 8,149 | 8,149 | 8,149 | 8,149 |
| End Cash Position | 1,735 | 2,223 | 5,959 | 2,137 | 4,957 |
| Net Cash Flow | $-488 | $-5,926 | $-2,189 | $-6,012 | $-3,192 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,880 | -14,300 | -10,581 | -6,279 | -3,095 |
| Capital Expenditure | -2 | -50 | -32 | -91 | -30 |
| Free Cash Flow | -1,883 | -14,350 | -10,613 | -6,371 | -3,125 |